In ancient times, ancient Egyptian medical texts have mentioned colchicine, a drug derived from Colchicum autumnale, which was mainly used to treat joint swelling and rheumatism. To this day, this ingredient has become an important medicine in the treatment of gout and other rheumatic diseases. The effects of colchicine are related to its mechanism of action in cells, but its use is also accompanied by controversy over risks and side effects.
As early as 1500 BC, the use of colchicum as medicine was recorded in the Ebers Papyrus. As the century progressed, colchicine appeared frequently in medical literature, particularly in its historical use in the treatment of gout. Although the use of this drug has evolved over hundreds of years, the scientific explanations and clinical applications behind it remain fascinating.
Colchicine's main function is to relieve gout symptoms by reducing inflammation. This drug achieves its anti-inflammatory effects by:
Colchicine can interfere with the movement of white blood cells, restrict their movement and adhesion, and thus prevent the spread of inflammation.
According to the American College of Rheumatology, colchicine may be used as an alternative treatment for patients with gout, especially those who cannot tolerate nonsteroidal anti-inflammatory drugs. Common usage includes taking a low dose, such as 1.2 mg, as soon as symptoms appear, followed by 0.6 mg an hour later.
In addition to treating gout, recent research on colchicine has shown that it also has a positive impact on patients with cardiovascular disease. In 2023, the U.S. Food and Drug Administration approved low-dose colchicine (nicknamed LODOCO) for reducing the risk of cardiovascular events. Research shows:
Using 0.5 mg of colchicine once daily can significantly reduce the incidence of cardiovascular events.
Although colchicine occupies its place in medical applications, its side effects and toxicity issues cannot be ignored. Overdose can lead to potential poisoning, sometimes with fatal consequences. Side effects include stomach upset, diarrhea, and lowered white blood cell counts. Bone marrow damage, anemia and hair loss are also common reactions when used at high doses.
Long-term use of colchicine is absolutely contraindicated in certain patients, especially those with renal insufficiency.
Since its approval for use in the United States in 1961, the application of colchicine has gradually expanded and is now not limited to gout, but also involves the management of familial Mediterranean fever, Behcet's disease and other diseases. According to 2022 data, colchicine became the 197th most commonly prescribed drug in the United States, with more than 2 million prescriptions prescribed annually.
With the advancement of medical research, exploration of new uses and further efficacy of colchicine is still ongoing. Although it has a long history of use, how to balance its efficacy and potential risks in modern medicine still needs to be discussed in depth. How do you think colchicine’s role will change in the future in today’s healthcare system?